Premium
Glutamate and schizophrenia: new insights, new treatments
Author(s) -
Greener Mark
Publication year - 2008
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.54
Subject(s) - schizophrenia (object oriented programming) , neuroscience , glutamate receptor , dopamine , dopamine hypothesis of schizophrenia , psychology , psychiatry , medicine , dopaminergic , receptor
There is increasing evidence to suggest that dopamine may not be as central to the pathogenesis of schizophrenia as previously believed. Here, Mark Greener provides an overview of studies supporting the primary role of glutamate in the development of schizophrenia and discusses its potential as a novel therapeutic target. Copyright © 2008 Wiley Interface Ltd